共 28 条
[1]
Yakhno N.N., Preobrazhenskaya I.S., Zakharov V.V., Et al., Prevalence of cognitive impairment in neurological diseases (Analysis of specialized outpatient care, 4, No. 2, pp. 30-35, (2012)
[2]
Luriya A.R., Higher Cortical Functions in Humans, Moscow State University, (1969)
[3]
Emelin A.Y., The possibilities of diagnosing and treating cognitive impairment at non-dementia stages, Nevrol. Neiropsikh. Psikhosom., 12, No. 5, pp. 78-83, (2020)
[4]
Del Sole A., Malaspina S., Magenta Biasina A., Magnetic resonance imaging and positron emission tomography in the diagnosis of neurodegenerative dementias, Funct. Neurol., 31, No. 4, pp. 205-215, (2016)
[5]
Herholz K., Westwood C., Haense evaluation of a calibrated (18)F-FDG PET score as a biomarker for progression in Alzheimer disease and mild cognitive impairment, J. Nucl. Med, 52, 8, pp. 1218-1226, (2011)
[6]
Litvinenko I.V., Emelinlobzin A.Y.V.Y., Et al., Neuroimaging techniques for diagnosing Alzheimer’s disease and cerebrovascular diseases with cognitive impairment, Nevrol. Neiropsikh. Psikhosom., 11, No. 3S,, pp. 18-25, (2019)
[7]
Jack C., Bennett D., Blennow K., Et al., NIA-AA Research Framework: Toward a biological definition of Alzheimer’s disease, Alzheimers Dement, 4, pp. 535-562, (2018)
[8]
Petersen R., Touchon J., Consensus on mild cognitive impairment: EADS-ADCS, Res. Pract. AD, 10, pp. 38-46
[9]
Hughes C., Berg L., Danziger W., Et al., A new clinical scale for the staging of dementia, Brit. J. Psychiatry, 140, pp. 566-572, (1982)
[10]
Yakhno N.N., Zakharov V.V., Cognitive and emotional-affective disorders in dyscirculatory encephalopathy, Ross. Med. Zh., 12, pp. 539-543